Raymond James Initiates Coverage On Q32 Bio with Strong Buy Rating, Announces Price Target of $90
Portfolio Pulse from Benzinga Newsdesk
Raymond James has initiated coverage on Q32 Bio (NASDAQ:QTTB) with a Strong Buy rating and set a price target of $90.
October 24, 2024 | 12:57 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Raymond James has initiated coverage on Q32 Bio with a Strong Buy rating and a price target of $90, indicating a positive outlook for the stock.
The initiation of coverage with a Strong Buy rating and a high price target by a reputable firm like Raymond James is likely to boost investor confidence and drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100